Syringotoxin B
| Internal ID | d1c228c3-cba4-4856-9881-8133ff3b6531 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 2-[(9Z)-24-(2-aminoethyl)-15-(3-aminopropyl)-3-(2-chloro-1-hydroxyethyl)-9-ethylidene-12-(1-hydroxyethyl)-18-(2-hydroxyethyl)-27-(3-hydroxytetradecanoylamino)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-6-yl]-2-hydroxyacetic acid |
| SMILES (Canonical) | CCCCCCCCCCCC(CC(=O)NC1COC(=O)C(NC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)CCN)CCO)CCCN)C(C)O)C(C(=O)O)O)C(CCl)O)O |
| SMILES (Isomeric) | CCCCCCCCCCCC(CC(=O)NC1COC(=O)C(NC(=O)C(NC(=O)/C(=C/C)/NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)CCN)CCO)CCCN)C(C)O)C(C(=O)O)O)C(CCl)O)O |
| InChI | InChI=1S/C48H82ClN11O18/c1-4-6-7-8-9-10-11-12-13-15-27(63)22-34(65)54-32-25-78-48(77)37(33(64)23-49)59-46(74)38(39(67)47(75)76)60-41(69)28(5-2)55-45(73)36(26(3)62)58-43(71)29(16-14-19-50)56-42(70)31(18-21-61)53-35(66)24-52-40(68)30(17-20-51)57-44(32)72/h5,26-27,29-33,36-39,61-64,67H,4,6-25,50-51H2,1-3H3,(H,52,68)(H,53,66)(H,54,65)(H,55,73)(H,56,70)(H,57,72)(H,58,71)(H,59,74)(H,60,69)(H,75,76)/b28-5- |
| InChI Key | GFIQMTUSPKSFSY-XNUQMYNASA-N |
| Popularity | 14 references in papers |
| Molecular Formula | C48H82ClN11O18 |
| Molecular Weight | 1136.70 g/mol |
| Exact Mass | 1135.5527825 g/mol |
| Topological Polar Surface Area (TPSA) | 479.00 Ų |
| XlogP | -2.50 |
| Atomic LogP (AlogP) | -5.36 |
| H-Bond Acceptor | 19 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 25 |
| 65547-14-0 |
| 2-[(9Z)-24-(2-aminoethyl)-15-(3-aminopropyl)-3-(2-chloro-1-hydroxyethyl)-9-ethylidene-12-(1-hydroxyethyl)-18-(2-hydroxyethyl)-27-(3-hydroxytetradecanoylamino)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-6-yl]-2-hydroxyacetic acid |
| Syringotoxin |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5774 | 57.74% |
| Caco-2 | - | 0.8595 | 85.95% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Mitochondria | 0.4866 | 48.66% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8151 | 81.51% |
| OATP1B3 inhibitior | + | 0.9185 | 91.85% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.8461 | 84.61% |
| P-glycoprotein inhibitior | + | 0.7410 | 74.10% |
| P-glycoprotein substrate | + | 0.8695 | 86.95% |
| CYP3A4 substrate | + | 0.7272 | 72.72% |
| CYP2C9 substrate | - | 0.8013 | 80.13% |
| CYP2D6 substrate | - | 0.8530 | 85.30% |
| CYP3A4 inhibition | - | 0.7329 | 73.29% |
| CYP2C9 inhibition | - | 0.8833 | 88.33% |
| CYP2C19 inhibition | - | 0.8609 | 86.09% |
| CYP2D6 inhibition | - | 0.9080 | 90.80% |
| CYP1A2 inhibition | - | 0.8636 | 86.36% |
| CYP2C8 inhibition | + | 0.7370 | 73.70% |
| CYP inhibitory promiscuity | - | 0.9805 | 98.05% |
| UGT catelyzed | - | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.7500 | 75.00% |
| Carcinogenicity (trinary) | Non-required | 0.5061 | 50.61% |
| Eye corrosion | - | 0.9825 | 98.25% |
| Eye irritation | - | 0.8969 | 89.69% |
| Skin irritation | - | 0.7526 | 75.26% |
| Skin corrosion | - | 0.9216 | 92.16% |
| Ames mutagenesis | - | 0.6200 | 62.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6464 | 64.64% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | - | 0.5603 | 56.03% |
| skin sensitisation | - | 0.8413 | 84.13% |
| Respiratory toxicity | + | 0.6889 | 68.89% |
| Reproductive toxicity | + | 0.8222 | 82.22% |
| Mitochondrial toxicity | + | 0.8250 | 82.50% |
| Nephrotoxicity | + | 0.9106 | 91.06% |
| Acute Oral Toxicity (c) | III | 0.6593 | 65.93% |
| Estrogen receptor binding | + | 0.7462 | 74.62% |
| Androgen receptor binding | + | 0.6889 | 68.89% |
| Thyroid receptor binding | - | 0.4946 | 49.46% |
| Glucocorticoid receptor binding | + | 0.5747 | 57.47% |
| Aromatase binding | + | 0.6627 | 66.27% |
| PPAR gamma | + | 0.7127 | 71.27% |
| Honey bee toxicity | - | 0.7319 | 73.19% |
| Biodegradation | - | 0.7750 | 77.50% |
| Crustacea aquatic toxicity | - | 0.5192 | 51.92% |
| Fish aquatic toxicity | + | 0.6775 | 67.75% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.91% | 83.82% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.74% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.44% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.18% | 96.09% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 97.85% | 89.63% |
| CHEMBL2581 | P07339 | Cathepsin D | 97.16% | 98.95% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 96.90% | 96.11% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 96.53% | 92.88% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 96.53% | 97.29% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 96.15% | 95.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.50% | 96.47% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 95.24% | 95.20% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.70% | 99.17% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 94.42% | 95.00% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 94.34% | 89.34% |
| CHEMBL236 | P41143 | Delta opioid receptor | 94.18% | 99.35% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 94.07% | 94.80% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 93.99% | 95.93% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 93.78% | 98.03% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 93.74% | 92.86% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 93.60% | 96.90% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 92.49% | 91.38% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.03% | 96.61% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.85% | 93.10% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 91.27% | 94.66% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.00% | 97.09% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 90.74% | 98.75% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 90.46% | 93.18% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 89.82% | 95.71% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 89.13% | 100.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 89.08% | 90.08% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.45% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 87.12% | 90.71% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 86.89% | 87.45% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 86.58% | 90.17% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 85.76% | 91.24% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 85.65% | 80.71% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 85.32% | 96.38% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 85.23% | 92.32% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 84.50% | 91.03% |
| CHEMBL1801 | P00747 | Plasminogen | 84.32% | 92.44% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 84.24% | 100.00% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 83.83% | 94.73% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.77% | 95.56% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 83.63% | 90.24% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 83.27% | 97.25% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 82.86% | 94.55% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 82.41% | 88.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 82.09% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.82% | 97.14% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 81.39% | 96.33% |
| CHEMBL3837 | P07711 | Cathepsin L | 80.72% | 96.61% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.69% | 89.50% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.53% | 94.33% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 80.23% | 92.29% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 80.00% | 97.64% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 6437367 |
| LOTUS | LTS0160043 |
| wikiData | Q105007561 |